Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Reference18 articles.
1. Long-term treatment with temozolomide in malignant glioma
2. Oncogene addiction in gliomas: Implications for molecular targeted therapy
3. Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
4. Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
5. Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway;Journal of Translational Medicine;2023-11-27
2. Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling;Frontiers in Pharmacology;2022-11-03
3. Norcantharidin alleviates cyclophosphamide-induced immunosuppression via circBCL2L1/miR-30c-3-3p/TRAF6 axis;Quality Assurance and Safety of Crops & Foods;2022-06-10
4. Association of RDM1 with osteosarcoma progression via cell cycle and MEK/ERK signalling pathway regulation;Journal of Cellular and Molecular Medicine;2021-07-15
5. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities;Chinese Medicine;2020-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3